Base editing shows promise for treating sickle cell disease and beta thalassemia

FHS
July 3, 2023
4:12 pm

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease (SCD) and beta thalassemia.

Pyxis cuts staff by 40% and pours resources into two cancer therapies – Pharmaceutical Technology

Pyxis plans to focus on developing its clinical pipeline, which consists of an antibody-drug conjugate (ADC), PYX-201 and a monoclonal antibody, PYX-106. Image Credit: inspiring.team

November 8, 2023

Melania Trump Says She Supports Abortion Rights, Putting Her at Odds With the GOP

Melania Trump revealed her support for abortion rights Thursday ahead of the release of her upcoming memoir, exposing a stark contrast with her husband, Republican

October 5, 2024

Terns’ GLP-1 pill leads to weight loss in early study

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Lots of bispecific talk

September 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.